Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR1 | P32241 | 4/20 | 0.61 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.59 |
| ▸ | GLP1R | P43220 | 10/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.56 |
| ▸ | GCGR | P47871 | 1/20 | 0.54 |
| ▸ | GIPR | P48546 | 1/20 | 0.54 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
| ▸ | CCKAR | P32238 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30483989 | 0.97 | VIPR1 (0.64) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL30484004 | 0.96 | VIPR1 (0.64) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL30879455 | 0.95 | VIPR1 (0.62) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL30912050 | 0.95 | VIPR1 (0.62) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL30483997 | 0.92 | VIPR1 (0.62) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL30483996 | 0.92 | VIPR1 (0.65) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL31066780 | 0.91 | GLP1R (0.61) | VIPR1GLP1R | |
| SCHEMBL30483987 | 0.91 | GLP1R (0.63) | VIPR1GLP1RECE1MUS81 | |
| SCHEMBL30483992 | 0.91 | VIPR1 (0.65) | VIPR1VIPR2GLP1RECE1MUS81 | |
| SCHEMBL31066777 | 0.90 | GLP1R (0.62) | VIPR1VIPR2GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240181015-A1 | EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2024-06-06 | — | — | US | disclosed |
| US-11993640-B2 | Treating inflammatory lung disease | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2024-05-28 | — | — | US | disclosed |
| US-20230126533-A1 | Method of treating an inflammatory disorder | UNIVERSITY OF MIAMI | 2023-04-27 | — | — | US | disclosed |